[…]
Ownership change 1998-2005

Timeline Post Type Description
Hexal acquired the plant from BMS to bypass certain product patents, for which only the production processes were patented in Denmark […]
Novartis acquired Hexal and merged it with Sandoz to create a leading generics player […]
ParmaZell acquired the plant with the purpose of using it as a technology base for API development […]
PharmaZell closed the plant as a part of its global restructuring process […]
The plant was acquired by Chr. Olesen Pharmaceuticals A/S, and COS was established […]
Re-establish production in synthetic workshop. Initial production of 4 APIs & 2 intermediates. […]
2014 commencing regular commercial production after GMP approval of key products mid year […]